Greenleaf Trust Position in Glaxosmithkline Plc Sponsored Adr (GSK) Upped by $337,995; Crown Castle Intl (Reit) (CCI) Holder Capital International Has Trimmed Its Position

April 17, 2018 - By Vivian Park

GlaxoSmithKline plc (NYSE:GSK) Logo

Capital International Inc decreased its stake in Crown Castle Intl Corp (Reit) (CCI) by 15.97% based on its latest 2017Q4 regulatory filing with the SEC. Capital International Inc sold 4,600 shares as the company’s stock rose 1.95% while stock markets declined. The institutional investor held 24,200 shares of the real estate investment trusts company at the end of 2017Q4, valued at $2.69M, down from 28,800 at the end of the previous reported quarter. Capital International Inc who had been investing in Crown Castle Intl Corp (Reit) for a number of months, seems to be less bullish one the $44.14 billion market cap company. The stock increased 1.99% or $2.08 during the last trading session, reaching $106.41. About 1.75M shares traded. Crown Castle International Corp. (NYSE:CCI) has risen 17.78% since April 17, 2017 and is uptrending. It has outperformed by 6.23% the S&P500.

Greenleaf Trust increased its stake in Glaxosmithkline Plc Sponsored Adr (GSK) by 672.03% based on its latest 2017Q4 regulatory filing with the SEC. Greenleaf Trust bought 9,657 shares as the company’s stock rose 9.28% while stock markets declined. The institutional investor held 11,094 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $394,000, up from 1,437 at the end of the previous reported quarter. Greenleaf Trust who had been investing in Glaxosmithkline Plc Sponsored Adr for a number of months, seems to be bullish on the $96.71B market cap company. The stock increased 0.12% or $0.05 during the last trading session, reaching $40.52. About 1.92M shares traded. GlaxoSmithKline plc (NYSE:GSK) has declined 10.07% since April 17, 2017 and is downtrending. It has underperformed by 21.62% the S&P500.

Capital International Inc, which manages about $18.21B and $672.30 million US Long portfolio, upped its stake in Yandex Nv A (NASDAQ:YNDX) by 42,710 shares to 372,635 shares, valued at $12.20 million in 2017Q4, according to the filing. It also increased its holding in Anadarko Petroleum Corp (NYSE:APC) by 6,100 shares in the quarter, for a total of 19,800 shares, and has risen its stake in Netease Inc Adr (NASDAQ:NTES).

Since February 21, 2018, it had 0 insider buys, and 2 insider sales for $2.03 million activity. Brown Jay A. had sold 18,000 shares worth $1.95 million.

Among 21 analysts covering Crown Castle International Corp (NYSE:CCI), 14 have Buy rating, 0 Sell and 7 Hold. Therefore 67% are positive. Crown Castle International Corp had 61 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Outperform” rating by Wells Fargo on Wednesday, March 8. Deutsche Bank maintained the shares of CCI in report on Thursday, June 8 with “Buy” rating. On Wednesday, July 19 the stock rating was maintained by Macquarie Research with “Buy”. As per Friday, January 26, the company rating was maintained by Guggenheim. The rating was maintained by Cowen & Co with “Buy” on Tuesday, July 18. RBC Capital Markets maintained it with “Buy” rating and $10700 target in Friday, July 7 report. The rating was maintained by RBC Capital Markets with “Buy” on Monday, August 28. Bank of America maintained the stock with “Buy” rating in Friday, September 8 report. The firm earned “Buy” rating on Tuesday, April 11 by Guggenheim. RBC Capital Markets maintained Crown Castle International Corp. (NYSE:REIT) rating on Wednesday, November 29. RBC Capital Markets has “Buy” rating and $125.0 target.

Investors sentiment decreased to 1.24 in Q4 2017. Its down 0.34, from 1.58 in 2017Q3. It fall, as 43 investors sold CCI shares while 214 reduced holdings. 84 funds opened positions while 235 raised stakes. 368.81 million shares or 2.36% less from 377.71 million shares in 2017Q3 were reported. Meiji Yasuda Life has 26,529 shares for 0.41% of their portfolio. 11,439 are held by Cetera Advisors Ltd Liability Corporation. Driehaus Ltd owns 0.08% invested in Crown Castle International Corp. (NYSE:REIT) for 19,700 shares. Axa holds 0.03% or 66,037 shares. Wellington Mgmt Grp Incorporated Llp holds 4.96M shares or 0.12% of its portfolio. Fincl Architects accumulated 2,313 shares. Congress Asset Ma holds 0.7% of its portfolio in Crown Castle International Corp. (NYSE:REIT) for 432,010 shares. California Employees Retirement System stated it has 848,367 shares. Parallax Volatility Advisers Limited Partnership holds 9,480 shares. Louisiana State Employees Retirement reported 24,600 shares. Fmr Ltd Limited Liability Company stated it has 1.32 million shares or 0.02% of all its holdings. Cibc Ww Markets Corp stated it has 82,115 shares or 0.07% of all its holdings. Oppenheimer & Com stated it has 0.03% in Crown Castle International Corp. (NYSE:REIT). Assetmark has invested 0% in Crown Castle International Corp. (NYSE:REIT). Main Street Ltd has invested 1.88% in Crown Castle International Corp. (NYSE:REIT).

Among 18 analysts covering GlaxoSmithKline (NYSE:GSK), 9 have Buy rating, 1 Sell and 8 Hold. Therefore 50% are positive. GlaxoSmithKline had 29 analyst reports since September 8, 2015 according to SRatingsIntel. The stock has “Overweight” rating by Piperjaffray on Friday, September 23. As per Monday, December 11, the company rating was maintained by Cowen & Co. The stock of GlaxoSmithKline plc (NYSE:GSK) earned “Hold” rating by Cantor Fitzgerald on Friday, February 26. Cowen & Co maintained GlaxoSmithKline plc (NYSE:GSK) on Wednesday, February 14 with “Hold” rating. BNP Paribas upgraded the shares of GSK in report on Wednesday, April 4 to “Buy” rating. The firm has “Neutral” rating by JP Morgan given on Wednesday, April 26. UBS upgraded GlaxoSmithKline plc (NYSE:GSK) on Monday, November 27 to “Buy” rating. The stock has “Buy” rating by Bryan Garnier & Cie on Wednesday, January 27. On Wednesday, April 5 the stock rating was upgraded by BNP Paribas to “Neutral”. BNP Paribas downgraded GlaxoSmithKline plc (NYSE:GSK) on Wednesday, September 14 to “Underperform” rating.

Greenleaf Trust, which manages about $4.93B US Long portfolio, decreased its stake in Jones Lang Lasalle Inc (NYSE:JLL) by 6,526 shares to 16,297 shares, valued at $2.43 million in 2017Q4, according to the filing. It also reduced its holding in Iac/Interactivecorp (NASDAQ:IACI) by 45,452 shares in the quarter, leaving it with 4,272 shares, and cut its stake in Anthem Inc (NYSE:ANTM).

GlaxoSmithKline plc (NYSE:GSK) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: